How Editing RNA—Not DNA—Could Cure Disease in the Future
By Kristen V. Brown,
Gizmodo
| 03. 15. 2018
DNA is the code of life, and so advances that allow us to edit that code have unlocked vast potential, from simply editing away the buggy code of disease, to engineering animals that don’t spread illness, to, maybe one day in a distant future, creating so-called designer babies. But editing another essential molecular component of our biology—RNA, the messenger used by cells to turns DNA instructions into proteins—also holds great promise.
A slew of recent high-profile discoveries have focused on pairing the buzzy genetic engineering tool, CRISPR, with RNA editing. RNA is a sort of middleman that turns genetic instructions from DNA into proteins. Editing RNA could allow scientists to tweak how genes are expressed without making permanent changes to the genome itself—thus avoiding one of the scarier aspects of genetic engineering, because you’d be interfering with DNA’s instructions rather than editing DNA itself. RNA is ephemeral, which means changes to it could be reversed. And in some diseases, like a form of muscular dystrophy called myotonic dystrophy, mutant RNA is actually the root of the problem.
In October...
Related Articles
Flag of South Africa; design by Frederick Brownell,
image by WikimediaCommons users.
Public domain, via Wikimedia Commons
What is the legal status of heritable human genome editing (HHGE)? In 2020, a comprehensive policy analysis by Baylis, Darnovsky, Hasson, and Krahn documented that more than 70 countries and an international treaty prohibit it, and that no country explicitly permits it. Policies in some countries were non-existent, ambiguous, or subject to possible amendment, but the general rule remained, even after one...
By Bernice Lottering, Gene Online | 11.08.2024
South Africa’s updated health-research ethics guidelines, which now include heritable human genome editing, have sparked concern among scientists. The revisions, made in May but only recently gaining attention, outline protocols for modifying genetic material in sperm, eggs, or embryos—changes...
By Jim Thomas, Scan the Horizon | 11.19.2024
It’s the wee hours of 2nd November 2024 in Cali, Colombia. In a large UN negotiating hall Colombian Environment Minister Susana Muhamed has slammed down the gavel on a decision that should send a jolt through the AI policy world. ...
By Ned Pagliarulo, BioPharmaDive | 11.05.2024
A medicine built around a more precise form of CRISPR gene editing appeared to work as designed in its first clinical trial test, developer Beam Therapeutics said Tuesday. But the death of a trial participant could renew concerns about an older...